Inhibrx Biosciences Inc (INBX)
15.45
-1.13
(-6.82%)
USD |
NASDAQ |
Nov 13, 16:00
15.56
+0.10
(+0.68%)
After-Hours: 20:00
Inhibrx Biosciences Price to Book Value: 1.020 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.020 |
| November 12, 2024 | 1.094 |
| November 11, 2024 | 1.056 |
| November 08, 2024 | 1.070 |
| November 07, 2024 | 1.073 |
| November 06, 2024 | 1.059 |
| November 05, 2024 | 1.037 |
| November 04, 2024 | 1.026 |
| November 01, 2024 | 1.043 |
| October 31, 2024 | 1.058 |
| October 30, 2024 | 1.075 |
| October 29, 2024 | 1.062 |
| October 28, 2024 | 1.056 |
| October 25, 2024 | 1.014 |
| October 24, 2024 | 1.014 |
| October 23, 2024 | 1.04 |
| October 22, 2024 | 1.043 |
| October 21, 2024 | 1.023 |
| October 18, 2024 | 1.056 |
| October 17, 2024 | 1.067 |
| October 16, 2024 | 1.059 |
| October 15, 2024 | 1.039 |
| October 14, 2024 | 1.023 |
| October 11, 2024 | 1.032 |
| October 10, 2024 | 1.028 |
| Date | Value |
|---|---|
| October 09, 2024 | 1.034 |
| October 08, 2024 | 1.055 |
| October 07, 2024 | 1.008 |
| October 04, 2024 | 0.974 |
| October 03, 2024 | 0.9819 |
| October 02, 2024 | 1.016 |
| October 01, 2024 | 1.020 |
| September 30, 2024 | 1.033 |
| September 27, 2024 | 1.024 |
| September 26, 2024 | 1.012 |
| September 25, 2024 | 1.018 |
| September 24, 2024 | 1.023 |
| September 23, 2024 | 1.034 |
| September 20, 2024 | 1.074 |
| September 19, 2024 | 1.154 |
| September 18, 2024 | 1.121 |
| September 17, 2024 | 1.136 |
| September 16, 2024 | 1.150 |
| September 13, 2024 | 1.083 |
| September 12, 2024 | 0.9951 |
| September 11, 2024 | 0.9898 |
| September 10, 2024 | 1.002 |
| September 09, 2024 | 1.003 |
| September 06, 2024 | 0.9938 |
| September 05, 2024 | 1.058 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7285
Minimum
Aug 09 2024
1.154
Maximum
Sep 19 2024
0.9645
Average
0.9945
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.573 |
| AIM ImmunoTech Inc | 2.511 |
| IGC Pharma Inc | 3.525 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.191 |
Price to Book Value Related Metrics
| PE Ratio | 0.1333 |
| Price | 15.45 |
| Earnings Yield | 750.4% |
| Market Cap | 223.65M |